Monday, December 21, 2020 - On the news of approval for Moderna’s coronavirus vaccine, major U.S. Indexes finished the week in the green. The U.S. is planning on pairing this roll out with the already approved Pfizer vaccine which not only investors, but the world, is hoping will be the beginning of the end for this pandemic.
For the week, the Dow Jones Industrial Average finished up .4% points closing at 30,179. The S&P 500 rose 1.3% to 3,663 while the Nasdaq Composite was the big winner for the week closing up 3.1% to 12,756.
ETFG Fund Flow SummaryIn ETFs, we saw outflows from some factor-based products. DGRW, the WisdomTree U.S. Quality Dividend Growth Fund, lost over $737M in assets during this week. That was followed by QUAL, the iShares MSCI USA Quality Factor ETF, which shed about $424M in assets. In inflows, we saw investors move their assets into some of the largest equity index-based ETFs in the marketplace. VXF, the Vanguard Extended Market Index Fund ETF, gained over $4.9B in AUM. That was followed by SPY, the State Street SPDR S&P 500 ETF, which gained over $3.2B in assets.
ETFG Weekly Select List - The five most highly rated ETFs per Sector, Geographic Region and Strategy as ranked by the ETFG Quant model.
Because of this strategy’s success, we highlight some substantial movement in the Industrials portion of this week’s Select List to last. The iShares U.S. Industrials ETF, IYJ, took over the 1st overall spot moving the iShares U.S. Aerospace & Defense ETF, ITAJETS, the U.S. Global Jets ETF held steady in 3rd while FLM, First Trust Global Engineering and Construction ETF and AIRR, he First Trust RBA American Industrial Renaissance ETF held steady at 4th and 5th.
This week, we will pay close attention to the news from Congress that the Senate has approved the next round of stimulus to help the American people battered from the Coronavirus. We will continue to learn more about the bill throughout the week but expect investors and the markets to greet the news with optimism.
Thanks for reading ETF Global Perspectives and have a great week!
ETFG 21 Day Free Trial: https://www.etfg.com/signup/quick
opinions and estimates constitute our judgment as of the date of this material
and are subject to change without notice.
ETF Global LLC (“ETFG”) and its affiliates and any third-party
providers, as well as their directors, officers, shareholders, employees or
agents (collectively ETFG Parties) do not guarantee the accuracy, completeness,
adequacy or timeliness of any information, including ratings and rankings and
are not responsible for errors and omissions or for the results obtained from
the use of such information and ETFG Parties shall have no liability for any
errors, omissions, or interruptions therein, regardless of the cause, or for
the results obtained from the use of such information. ETFG PARTIES DISCLAIM
ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO ANY
WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE
In no event shall ETFG Parties be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of the information contained in this document even if advised of the possibility of such damages.
ETFG ratings and rankings are statements of opinion as of the date they are expressed and not statements of fact or recommendations to purchase, hold, or sell any securities or to make any investment decisions. ETFG ratings and rankings should not be relied on when making any investment or other business decision. ETFG’s opinions and analyses do not address the suitability of any security. ETFG does not act as a fiduciary or an investment advisor. While ETFG has obtained information from sources they believe to be reliable, ETFG does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives.
This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument. Securities, financial instruments or strategies mentioned herein may not be suitable for all investors. Any opinions expressed herein are given in good faith, are subject to change without notice, and are only correct as of the stated date of their issue. Prices, values, or income from any securities or investments mentioned in this report may fall against the interests of the investor and the investor may get back less than the amount invested. Where an investment is described as being likely to yield income, please note that the amount of income that the investor will receive from such an investment may fluctuate. Where an investment or security is denominated in a different currency to the investor's currency of reference, changes in rates of exchange may have an adverse effect on the value, price or income.